Mission Statement, Vision, & Core Values (2026) of Jiangsu Kanion Pharmaceutical Co.,Ltd.

Founded in 1991, Jiangsu Kanion Pharmaceutical Co., Ltd. has grown into a powerhouse of modern Chinese medicine with over 5,000 employees, national-level research platforms such as the State Key Laboratory of New Technology of Pharmaceutical Process of Chinese Materia Medica, recognition as a National Key High-tech Enterprise and repeated listings among the Top 100 Chinese Pharmaceutical Innovation Enterprises and Top 10 most investment-worthy pharmaceutical listed firms; its portfolio spans Chinese patent medicines, formula granules and chemical/biological drugs, backed by a research team where more than 60% hold doctoral or master's degrees, a first intelligent manufacturing factory designated as a pilot project by the Ministry of Industry and Information Technology, rigorous quality controls, and a global sales network exporting to North America, Europe and Southeast Asia that together drive Kanion's mission to modernize and internationalize traditional Chinese medicine through science-led innovation and social responsibility

Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) - Intro

• Founded: 1991
• Headcount: >5,000 employees (≈5,200 total staff)
• Listed: Shanghai Stock Exchange (600557.SS)
• National recognitions: National Key High-tech Enterprise; National Technological Innovation Demonstration Enterprise

Mission

• Deliver safe, effective modern Chinese medicines grounded in evidence-based research.
• Preserve and modernize Chinese materia medica through scientific innovation and quality manufacturing.
• Create sustainable value for patients, healthcare partners, employees, and shareholders.

Vision

• Become a globally respected leader in modern Chinese medicine and integrated biopharmaceuticals.
• Advance international acceptance of Chinese patent medicines and standardized herbal formula granules.
• Build globally certified R&D and production platforms to support next-generation CHM and biological therapeutics.

Core Values

• Science-led innovation: prioritize rigorous R&D, clinical validation, and quality control.
• Patient-centricity: safety, efficacy, accessibility.
• Integrity & compliance: GMP, GCP, and international regulatory alignment.
• Collaboration: partnerships with academic institutions, hospitals, and global distributors.
• Sustainability: responsible sourcing of Chinese medicinal materials and environmental stewardship.

Scientific & Innovation Platforms

• State Key Laboratory-level platform: State Key Laboratory of New Technology of Pharmaceutical Process of Chinese Material Medica.
• National-level research platforms and R&D centers supporting formulation, process engineering, and clinical research.
• Comprehensive QC and analytical labs for botanical raw materials, formula granules, and biological products.

Product Portfolio & Capabilities

• Chinese patent medicines (proprietary formula products)
• Formula granules (standardized Chinese herbal extracts for clinical and hospital use)
• Chemical medicines and biological medicines (small molecules and biologics in development/production)

Global Market & Exports

• Established global sales network with exports across North America, Europe, and Southeast Asia.
• Strategic focus on hospital channels, distributors, and cross-border e-commerce for formula granules and patent medicines.
• Ongoing regulatory engagement to expand approvals and registrations internationally.

Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) - Overview

Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) centers its corporate purpose on advancing modern Chinese medicine through scientific rigor, innovation and large-scale manufacturing. The company's mission, vision and core values knit together research intensity, quality assurance and social responsibility to position Kanion as a leading integrator of traditional Chinese medicine (TCM) into modern healthcare systems at home and abroad.

Mission Statement

Kanion is dedicated to the research, production, and sales of modern Chinese medicine, aiming to promote the high-quality development of traditional Chinese medicine through inheritance and innovation. Key mission pillars include:

• Intensive R&D to translate TCM knowledge into standardized, evidence-based pharmaceutical products.
• Stringent quality controls to ensure product safety, efficacy and regulatory compliance across markets.
• Global health impact by expanding access to high-quality TCM-derived therapeutics.
• Corporate social responsibility through community support and sustainable manufacturing practices.

Vision

To be a globally respected leader in modern Chinese medicine, integrating centuries of TCM heritage with cutting-edge pharmaceutical science to deliver reliable, clinically validated therapies that meet international standards.

Core Values

• Innovation - sustained investment in discovery and product development to create differentiated TCM therapeutics.
• Quality First - comprehensive quality management from raw materials to finished products and pharmacovigilance.
• Integrity - transparent governance, ethical research and compliance with domestic and international regulations.
• Patient-centricity - prioritizing safety, clinical effectiveness and accessibility for patients.
• Sustainability & Community - minimizing environmental footprint and supporting local health initiatives.

R&D and Recognition

Kanion emphasizes innovation in developing new and effective medications and has been recognized for its R&D achievements:

• Listed among the 'Top 100 Chinese Pharmaceutical Innovation Enterprises.'
• Named one of the 'Top 10 Most Investment-worthy Chinese Pharmaceutical Listed Enterprises.'
• R&D-driven pipeline combining standardized botanical extracts, modern formulations and clinical research.

Key Operational & Financial Metrics (Selected, approximate)

Quality, Compliance & Global Reach

Kanion maintains stringent quality controls-from supplier qualification and standardized extraction to stability testing and post-market surveillance-to ensure product safety and efficacy. The company pursues regulatory approvals and partnerships to expand international distribution of its modern TCM products.

For corporate history, ownership structure and more operational detail, see: Jiangsu Kanion Pharmaceutical Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) - Mission Statement

• Become a first‑class enterprise in global pharmaceutical and healthcare markets by upgrading manufacturing and regulatory compliance to international benchmarks.
• Drive modernization and internationalization of traditional Chinese medicine through evidence‑based R&D and standardized production processes.
• Promote science and technology as the core engines for product innovation, new drug development, and improved clinical outcomes.
• Invest in human capital: maintain a research team where over 60% of members hold doctoral or master's degrees to ensure high‑level scientific capacity.

• Advanced research team: more than 60% with master's/PhD degrees, concentrated in pharmacology, natural products chemistry, manufacturing engineering, and clinical research.
• Intelligent manufacturing: established the first intelligent manufacturing factory for TCM digitalization, designated as a pilot project by the Ministry of Industry and Information Technology (MIIT) to promote industry 4.0 practices in TCM production.
• Technology roadmap: continuous upgrades of manufacturing technology and equipment aimed at reaching top international drug manufacturing standards (GMP, automation, digital quality control).

• Scale up GMP‑compliant, automated production lines to reduce variability and meet international regulatory expectations.
• Expand clinical and translational research to validate TCM mechanisms and broaden indications for international markets.
• Leverage digitalization and smart manufacturing to shorten time‑to‑market, improve traceability, and lower cost‑per‑unit.
• Strengthen strategic partnerships and licensing to accelerate overseas market entry and diversify revenue streams.

Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) - Vision Statement

• Commitment to quality: "High-quality Chinese medicine, made in KANION."
• Innovation-driven growth: sustained investment in scientific research and technology.
• Modernization & internationalization: bringing standardized, scalable TCM to global markets.
• Science-led progress: using digitalization and intelligent manufacturing to raise industry benchmarks.

• R&D capacity: concentrated expert talent with a high proportion of advanced degrees to drive formulation optimization, clinical validation, and product standardization.
• Digital & manufacturing leadership: leveraging data-driven production lines to ensure batch traceability, process control, and scale-up for export markets.
• Responsibility to TCM modernization: integrating pharmacology, quality science, and global regulatory pathways to elevate TCM credibility internationally.